Overview

Warp Sciences is a US-based chemistry contract research organization (CRO) that combines chemists, artificial intelligence, and robotics to create and test molecules for biotech and pharmaceutical companies. It does not own a drug pipeline; customers decide which molecules to pursue and retain control of their drug programs. Its initial service is lead-optimization analog synthesis, where variations of promising molecules are produced and compared by research teams to select drug candidates. Chemists design experiments while the lab becomes increasingly automated; data from experiments trains AI models that help run the lab more efficiently. Customers pay per compound delivered. The company aims to bring discovery chemistry work back to the United States and was founded by Kevin Weil, DJ Patil, Sol Reisberg, and Mano Paluri, with backing from investors like Lightspeed and Mayfield.